LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference
LENSAR, a global medical technology leader in femtosecond laser surgical solutions for cataracts, announced CEO Nick Curtis will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021. The presentation will be available on-demand starting at 7:00 a.m. ET and can be accessed through the Company's website. LENSAR specializes in advanced laser systems designed to improve visual outcomes and efficiency in cataract surgery.
- None.
- None.
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021.
Mr. Curtis’ presentation will be available on-demand beginning at 7:00 a.m. Eastern Time on August 17, 2021 and can be accessed through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005076/en/
FAQ
When will LENSAR present at the H.C. Wainwright Ophthalmology Virtual Conference?
What time will the LENSAR presentation be available?
Where can I access the LENSAR presentation?
What technology does LENSAR focus on for cataract treatment?